BNGO Annual Accounts Receivable
$9.32 M
+$2.30 M+32.71%
31 December 2023
Summary:
As of January 23, 2025, BNGO annual accounts receivable is $9.32 million, with the most recent change of +$2.30 million (+32.71%) on December 31, 2023. During the last 3 years, it has risen by +$6.54 million (+235.82%). BNGO annual accounts receivable is now at all-time high.BNGO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNGO Quarterly Accounts Receivable
$5.32 M
-$939.00 K-15.01%
01 September 2024
Summary:
As of January 23, 2025, BNGO quarterly accounts receivable is $5.32 million, with the most recent change of -$939.00 thousand (-15.01%) on September 1, 2024. Over the past year, it has dropped by -$939.00 thousand (-15.01%). BNGO quarterly accounts receivable is now -42.96% below its all-time high of $9.32 million, reached on December 31, 2023.BNGO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNGO Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.7% | -15.0% |
| 3 y3 years | +235.8% | +77.4% |
| 5 y5 years | +106.4% | -11.4% |
BNGO Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.9% | -43.0% | +9.6% |
| 5 y | 5-year | at high | +235.8% | -43.0% | +166.9% |
| alltime | all time | at high | +404.7% | -43.0% | +166.9% |
Bionano Genomics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.32 M(-15.0%) |
| June 2024 | - | $6.25 M(-24.8%) |
| Mar 2024 | - | $8.31 M(-10.8%) |
| Dec 2023 | $9.32 M(+32.7%) | $9.32 M(+7.5%) |
| Sept 2023 | - | $8.67 M(+13.9%) |
| June 2023 | - | $7.61 M(+12.3%) |
| Mar 2023 | - | $6.78 M(-3.4%) |
| Dec 2022 | $7.02 M(+42.3%) | $7.02 M(+20.5%) |
| Sept 2022 | - | $5.83 M(+20.2%) |
| June 2022 | - | $4.85 M(-12.0%) |
| Mar 2022 | - | $5.51 M(+11.8%) |
| Dec 2021 | $4.93 M | $4.93 M(+64.7%) |
| Sept 2021 | - | $3.00 M(+5.6%) |
| June 2021 | - | $2.84 M(+42.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $1.99 M(-28.2%) |
| Dec 2020 | $2.77 M(-56.2%) | $2.77 M(-28.1%) |
| Sept 2020 | - | $3.86 M(+18.8%) |
| June 2020 | - | $3.25 M(-21.0%) |
| Mar 2020 | - | $4.12 M(-35.0%) |
| Dec 2019 | $6.33 M(+40.3%) | $6.33 M(+5.6%) |
| Sept 2019 | - | $6.00 M(+20.4%) |
| June 2019 | - | $4.98 M(+22.8%) |
| Mar 2019 | - | $4.06 M(-10.1%) |
| Dec 2018 | $4.51 M(+34.7%) | $4.51 M(+12.8%) |
| Sept 2018 | - | $4.00 M(+38.6%) |
| June 2018 | - | $2.89 M(+13.8%) |
| Mar 2018 | - | $2.54 M(-24.4%) |
| Dec 2017 | $3.35 M(+81.5%) | $3.35 M |
| Dec 2016 | $1.85 M | - |
FAQ
- What is Bionano Genomics annual accounts receivable?
- What is the all time high annual accounts receivable for Bionano Genomics?
- What is Bionano Genomics annual accounts receivable year-on-year change?
- What is Bionano Genomics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Bionano Genomics?
- What is Bionano Genomics quarterly accounts receivable year-on-year change?
What is Bionano Genomics annual accounts receivable?
The current annual accounts receivable of BNGO is $9.32 M
What is the all time high annual accounts receivable for Bionano Genomics?
Bionano Genomics all-time high annual accounts receivable is $9.32 M
What is Bionano Genomics annual accounts receivable year-on-year change?
Over the past year, BNGO annual accounts receivable has changed by +$2.30 M (+32.71%)
What is Bionano Genomics quarterly accounts receivable?
The current quarterly accounts receivable of BNGO is $5.32 M
What is the all time high quarterly accounts receivable for Bionano Genomics?
Bionano Genomics all-time high quarterly accounts receivable is $9.32 M
What is Bionano Genomics quarterly accounts receivable year-on-year change?
Over the past year, BNGO quarterly accounts receivable has changed by -$939.00 K (-15.01%)